Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Reuter

Showing results (431-440 of 581) with videos related to

Pageof 59
Sort By:
The American Journal of Surgical Pathology|September 2, 2011
Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomasLuciana Schultz, Alcides Chaux, Roula Albadine, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1997
Cigarette smoking and chromosome 9 alterations in bladder cancerZ F Zhang, X M Shu, C Cordon-Cardo, et al.
Molecular Cancer|May 20, 2004
Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumorsSanjay Koul, James M McKiernan, Gopeshwar Narayan, et al.
The Journal of Urology|December 24, 2019
Long-Term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center ExperienceSigrid Carlsson, Nicole Benfante, Ricardo Alvim, et al.
British Journal of Clinical Pharmacology|January 24, 2019
Population pharmacokinetics of lenalidomide in patients with B-cell malignanciesJim H Hughes, Mitch A Phelps, Richard N Upton, et al.
Radiology|September 7, 2012
Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective studyHebert Alberto Vargas, Oguz Akin, Amita Shukla-Dave, et al.
Urology Practice|May 5, 2023
Impact of Zone of Origin in Anterior Dominant Prostate Cancer: Long-Term Biochemical Recurrence-Free Survival in an Anatomically Well-Characterized CohortSamson W Fine, Hikmat A Al-Ahmadie, Emily Vertosick, et al.
Therapeutic Drug Monitoring|December 9, 2021
Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyStephanie E Reuter, Sophie L Stocker, Jan-Willem C Alffenaar, et al.
The Journal of Urology|October 16, 2012
Prognostic impact of subclassification of radical prostatectomy positive margins by linear extent and Gleason gradeKazuma Udo, Angel M Cronin, Lauren J Carlino, et al.
Nature Medicine|January 14, 1998
Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progressionC N Papandreou, B Usmani, Y Geng, et al.
Pageof 59

Showing results (431-440 of 581) with videos related to

Sort By:
Pageof 59
The American Journal of Surgical Pathology|September 2, 2011
Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomasLuciana Schultz, Alcides Chaux, Roula Albadine, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1997
Cigarette smoking and chromosome 9 alterations in bladder cancerZ F Zhang, X M Shu, C Cordon-Cardo, et al.
Molecular Cancer|May 20, 2004
Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumorsSanjay Koul, James M McKiernan, Gopeshwar Narayan, et al.
The Journal of Urology|December 24, 2019
Long-Term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center ExperienceSigrid Carlsson, Nicole Benfante, Ricardo Alvim, et al.
British Journal of Clinical Pharmacology|January 24, 2019
Population pharmacokinetics of lenalidomide in patients with B-cell malignanciesJim H Hughes, Mitch A Phelps, Richard N Upton, et al.
Radiology|September 7, 2012
Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective studyHebert Alberto Vargas, Oguz Akin, Amita Shukla-Dave, et al.
Urology Practice|May 5, 2023
Impact of Zone of Origin in Anterior Dominant Prostate Cancer: Long-Term Biochemical Recurrence-Free Survival in an Anatomically Well-Characterized CohortSamson W Fine, Hikmat A Al-Ahmadie, Emily Vertosick, et al.
Therapeutic Drug Monitoring|December 9, 2021
Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyStephanie E Reuter, Sophie L Stocker, Jan-Willem C Alffenaar, et al.
The Journal of Urology|October 16, 2012
Prognostic impact of subclassification of radical prostatectomy positive margins by linear extent and Gleason gradeKazuma Udo, Angel M Cronin, Lauren J Carlino, et al.
Nature Medicine|January 14, 1998
Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progressionC N Papandreou, B Usmani, Y Geng, et al.
Pageof 59